Position Paper European Breast Cancer Council manifesto 2018 : Genetic risk prediction testing in breast cancer

a Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands b Medical Oncology Department, University Hospital Vall D’Hebron, Barcelona, Spain c European School of Oncology, Milan, Italy d Europa Donna e The European Breast Cancer Coalition, Milan, Italy e Department of Genomic Medicine, Division of Evolution and Genomic Science, University of Manchester, St Mary’s Hospital, Manchester, United Kingdom f School of Medicine, Cardiff University, Cardiff, United Kingdom g Department of Oncology, Cambridge, United Kingdom h Department of Public Health and Primary Care, Strangeways Research Laboratory, Cambridge, United Kingdom i Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands j Department of Genetics, Institut Curie, Paris, France k University Paris Descartes, Paris, France l Psycho-Oncology, Champalimaud Clinical Center, Lisbon, Portugal m Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom n Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, United Kingdom